UBS Group’s Rezolve AI RZLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
3,400,537
+1,106,175
+48% +$2.91M ﹤0.01% 3366
2026
Q1
$5.87M Buy
2,294,362
+1,659,037
+261% +$4.68M ﹤0.01% 3898
2025
Q4
$1.63M Buy
635,325
+122,714
+24% +$463K ﹤0.01% 5146
2025
Q3
$2.55M Buy
512,611
+310,371
+153% +$1.22M ﹤0.01% 4722
2025
Q2
$622K Sell
202,240
-229,635
-53% -$452K ﹤0.01% 5839
2025
Q1
$523K Buy
431,875
+347,943
+415% +$823K ﹤0.01% 5823
2024
Q4
$321K Buy
+83,932
New +$346K ﹤0.01% 6160

Other funds holding RZLV

UBS Group's RZLV Position: Q2 2026 in Review

UBS Group increased its Rezolve AI (RZLV) stake by 48% in Q2 2026, buying an estimated $2.91M and bringing the position to 3,400,537 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

UBS Group first reported a position in RZLV in Q4 2024 and has held it in 7 quarters since. 115 funds tracked by Wall St. Rank hold RZLV as of Q2 2026.

  • UBS Group held 3,400,537 shares of Rezolve AI worth $10.7M as of Q2 2026.
  • UBS Group bought 1,106,175 Rezolve AI shares in Q2 2026, an estimated $2.91M.
  • Rezolve AI made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3366 holding.
  • UBS Group first reported a position in Rezolve AI in Q4 2024 and has held it in 7 quarters since.
  • 115 funds tracked by Wall St. Rank held Rezolve AI as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.